RedHill Biopharma Ltd. (RDHL) [Rocket]

In millions, except per share items	Mar-31-21	Mar-31-20	Sep-30-19	Mar-31-19	Sep-30-18	Mar-31-18	Mar-31-17
	6-K	6-K	6-K	6-K	6-K	6-K	6-K
OPERATING ACTIVITIES:
Comprehensive loss
Adjustments in respect of income and expenses not involving cash flow:
Share-based compensation to employees and service providers
Depreciation
Amortization and impairment of intangible assets
Non-cash interest expenses related to borrowing and payable in respect of intangible assets purchase
Fair value adjustments on derivative financial instruments
Fair value (gains) losses on financial assets at fair value through profit or loss
Exchange differences and revaluation of bank deposits
Total adjustments in respect of income and expenses not involving cash flow
Changes in assets and liability items:
Increase in trade receivables
Decrease (increase) in prepaid expenses and other receivables
Increase in inventories
Increase in accounts payable
Total changes in assets and liability items
Net cash used in operating activities
INVESTING ACTIVITIES:
Purchase of fixed assets
Purchase of intangible assets
Purchase of financial assets at fair value through profit or loss
Proceeds from sale of financial assets at fair value through profit or loss
Net cash provided by (used in) investing activities
FINANCING ACTIVITIES:
Proceeds from issuance of ordinary shares, net of issuance costs
Payment of principal with respect to lease liabilities
Net cash provided by financing activities
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS
BALANCE OF CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD
BALANCE OF CASH AND CASH EQUIVALENTS AT END OF PERIOD